Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine
This article was originally published in PharmAsia News
An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry
You may also be interested in...
In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the 32nd annual Goldman Sachs Global Healthcare Conference ('Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference,' PharmAsia News, June 15, 2011). For this profile, we zoom in on the Morgan Stanley Global Healthcare Conference, held Sept. 13-14 in New York.
Regulatory And Staffing Challenges For Private Hospitals In Southeast Asia - Private Healthcare World Asia 2011
SINGAPORE - Investor interest in Asia's private hospital infrastructure remains strong but regulatory limitation and lack of professional staff stymies its huge potential, industry experts told a Singapore conference June 15
Drug makers need to more aggressively target so-called "pharmerging" markets - but not just the usual suspects. Brazil, Russia, India and China remain highly important, but in a March 16 report, IMS Health predicts that 17 countries, in total, will contribute 48 percent of annual market growth in 2013, up from 37 percent last year